Goal 3: Reduce Related Harm for Patients with Behavioral Health Disorder

Added controlled substance symbols to the medication administration record (MAR) for better identification of controlled substances to increase adherence to related policy/procedures and to enhance patient safety.

Added the pain score monitoring report to the adult overview summary.

Made Vivitrol injection available at no cost to patients in the inpatient substance abuse unit to prevent relapse to opioid dependence.

Created a buprenorphine induction protocol and order set for implementation in the emergency department and inpatient units.

Distributed Xylazine education to all staff when Xylazine use was observed in the community then shortly thereafter successfully treated our first patients at Florence and Edgewood

Established a best practice alert (BPA) to limit concurrent prescribing of opioids and benzodiazepines.

Created a BPA to offer Naloxone when patients are prescribed opioids containing more than 50 morphine milligram equivalents (MMEs).

Removed the default long-acting oxycodone from pre anesthesia order sets.

Added medication take back bins in the Cancer Center Pharmacy.

Eliminated the care plan BPA and added opiates for pain to the patient’s chart for ease of nurse navigation.

Updated MME conversion factors to reflect Centers for Disease Control and Prevention (CDC) changes.